A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Authors: Alexander C. Huang, Robert Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George, Patrick Yan, Sasikanth Manne, Adam Kraya, Bradley Wubbenhorst, Liza M. Dorfman, Kurt D’Andrea, Brandon M. Wenz, Shujing Liu, Lakshmi Chilukuri, Andrew Kozlov, Mary Carberry, Lydia Giles, Melanie Wain Kier, Felix Quagliarello, Suzanne McGettigan, Kristin Kreider, Lakshmanan Annamalai, Qing Zhao, Robin Mogg, Wei Xu, Wendy M. Blumenschein, Jennifer H. Yearley, Gerald P. Linette, Ravi K. Amaravadi, Lynn M. Schuchter, Ramin S. Herati, Bertram Bengsch, Katherine L. Nathanson, Michael D. Farwell, Giorgos C. Karakousis, E. John Wherry, Tara C. Mitchell - Nature Medicine 2019 cited by 702